Is AI Changing Pharma Jobs or Just Company Messaging?

Is AI changing the Pharma and Biotech job market? As companies continue to “invest heavily in AI” and announce partnerships, the prevailing narrative seems to be that AI is dramatically improving efficiencies and changing how people work. However, what companies say is often quite different from what they do. Here, we’ll take a look at roughly 94k job postings from 41 biotech and pharma companies from Q3 2025 to Q3 2026 to see whether roles and descriptions are changing in 2026.

How Would We Know if AI Was Changing the Pharma Job Market? #

Job postings can provide an inside view of company strategy and values. Are companies preparing for an IPO? Growing their MSL team in preparation for an anticipated approval? Even absent press releases, job postings can be informative about underlying strategy.

If pharma is truly transforming their business with AI, what might we expect to see?

1. Open Jobs would be decreasing because companies are working more efficiently with fewer people
2. Remaining Job postings would mention AI more and describe the specific experience they needed to fill the roles
3. New roles would emerge as technology advances

Job Postings Have Not Decreased #

Looking at Q3 2026, our job data indicates that postings have actually increased ~23% compared to Q3 2025. The companies I’ve monitored have actually posted more jobs in 2026.

The named categories PharmaPayWatch tracks did not change much, so the broad job category mix was roughly similar.

Job postings don’t necessarily indicate more hiring or job availability, but it is useful to compare similar seasons and behavior over time.

AI-term Mentions have Increased in Job Postings #

How often do companies mention AI in the jobs they post? Here I used a simple word search, counting a posting as an AI mention if its description included terms like “AI”, “artificial intelligence”, “generative AI”, “LLM”, “agentic”, “Copilot”, “Claude”, or “ChatGPT”. The share of new postings that mention AI more than doubled in a year, from about 10% in Q3 2025 to nearly 23% in Q3 2026.

However, “AI terms” in a job posting can be quite vague and reflect company aspirations or positioning rather than concrete job functions. So we sorted each AI mention into one of two groups using simple word rules:

• Concrete: names a specific tool or technique, or makes a firm requirement (hands-on experience, years of experience, required).
• Vague: includes company messaging (“an AI-powered biopharma company”), soft phrasing like “openness” or “curiosity about AI”, or general other references to AI with no specific ask.

As expected, vague language and company messaging dominates AI mentions in job postings. Some typical examples include:

• “openness to AI-enabled processes”
• “familiarity and basic understanding of common AI tools and a curiosity for learning how they can be used to enhance productivity”
• “a passion for emerging technologies…including AI-enabled approaches”

Concrete asks have more specific ideas about use, describing what “AI” would actually be used for:

• experience applying AI/ML to improve laboratory workflows
• hands-on experience applying AI to model building and workflow automation
• defining use cases and standard prompt patterns for AI-assisted analytics
• comfort with AI coding agents like Claude Code

While some of these concrete examples may still be considered vague to practitioners, they are at least more grounded in real job functions. Both types of phrasing doubled when comparing Q3 2025 to Q3 2026.

New Roles are Emerging #

I also looked at job titles themselves. Postings with AI in the title (e.g., AI, machine learning, generative AI, LLM) more than doubled, from 172 in Q3 2025 to 418 in Q3 2026. While only about 2% of postings, this share held steady over the last two quarters.

Here are a few newer titles related to AI or technology:

• “Agentic” titles, such as “Head of Agentic Biology” and “Head of Agentic Factory.” These were already appearing in early 2025, but they’ve picked up sharply this year.
• “Forward deployed engineers.” The title is borrowed from tech companies like Palantir, and it first showed up in our data in December 2025. Since then, we’ve seen 23 of these postings at 11 companies, often attached to a specific function like finance, supply chain, or even the office of the CEO.
• Autonomous lab roles, first seen in April 2026, with titles built around “autonomous labs” and “autonomous discovery.”

Agentic titles were already appearing when our data collection began in early 2025, but forward deployed first appeared during the past year. As a former biotech consultant, I found these roles stood out the most, since putting engineers directly inside business functions like finance or supply chain, rather than in a central IT or data team, suggests some companies may be starting to rework how existing roles get done.

What Job Postings Tell Us So Far #

So is AI changing the market or is it just messaging? The answer so far is both!

Job posts aren’t decreasing, and while companies are adding much more vague AI keywords to posts, they are also adding more concrete asks and creating new AI-focused roles.

It is important to note that job postings are messy and often read like keyword soup. They are most useful in aggregate, compared within or across companies over time. I’ll keep monitoring these changes across the industry at PharmaPayWatch.com.